-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Med-X Announces Distribution Agreement With Ensystex for Nature-Cide Portfolio of Products
Med-X Announces Distribution Agreement With Ensystex for Nature-Cide Portfolio of Products
Leading Supplier to Pest Management Professionals to Further Enhance Nature-Cide's Growing Global Distribution Network
LOS ANGELES, CA / ACCESSWIRE / November 14, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, announced today that it has entered into a distribution agreement with Ensystex, a leading supplier to pest management professionals, for multiple products in its Nature-Cide Professional pest control line.
Ensystex was founded in 1994 by pest control operators intent on changing the landscape of the professional pest control industry. Ensystex has the expertise to synthesize, source, formulate, manufacture, promote and distribute a wide range of products to pest management professionals. With products for termite and general pest control - as well as turf and ornamental - the company sells to thousands of pest management professionals around the world.
Per the terms of the agreement, Ensystex will distribute Med-X's Nature-Cide portfolio of indoor and outdoor pest control solutions to a wide variety of professional pest management customers through its direct field representatives located throughout the United States. Products for distribution will include Nature-Cide All Purpose Concentrate, Pest Management X2 and Insecticidal Dust.
"Ensystex has deep experience in the pest management industry, and their team believes in delivering the most effective products to their demanding professional customer base," said Jennifer Mills, President of Med-X. "Their mission to be the premier supplier of pest management products to the structural pest control industry strongly complements our existing national distribution coverage. The addition of our all-natural pest control solutions uniquely enables the use of insecticides without fear of harming the environment, helping to expand and diversify their portfolio. Our distribution partnership and mutual commitment to provide proven pest control solutions to pest management professionals will enable us to expand our reach and supply our solutions to an increasingly broad spectrum of customers."
Shelley Moats of Ensystex added: "We look forward to the opportunity to carry Nature-Cide's range of environmentally friendly and effective solutions, introducing these additional tools to broaden our product line and help enhance our customers' pest management programs. Ensystex's focus has always been to provide our customers with cost-effective solutions and this partnership supports our desire to offer a high-quality, all-natural solution for their use."
About Med-X, Inc.
Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit .
Disclaimer and Forward-Looking Statements
The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the Regulation A+ Offering Circular Securities and Exchange Commission filings before making any investment in the Company. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.
Investor Relations Contact
Lucas Zimmerman
Director
MZ Group - MZ North America
949-259-4987
MXRX@mzgroup.us
SOURCE: Med-X, Inc.
Leading Supplier to Pest Management Professionals to Further Enhance Nature-Cide's Growing Global Distribution Network
害虫管理专业人员的领先供应商进一步加强自然-Cide不断增长的全球分销网络
LOS ANGELES, CA / ACCESSWIRE / November 14, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, announced today that it has entered into a distribution agreement with Ensystex, a leading supplier to pest management professionals, for multiple products in its Nature-Cide Professional pest control line.
加利福尼亚州洛杉矶/ACCESSWIRE/2022年11月14日/面向虫害控制、健康和保健市场的全天然绿色场景解决方案的领先创新者Med-X公司今天宣布,它已经与虫害管理专业人员的领先供应商Ensystex达成了一项经销协议,销售其自然-Cide专业虫害防治系列的多种产品。
Ensystex was founded in 1994 by pest control operators intent on changing the landscape of the professional pest control industry. Ensystex has the expertise to synthesize, source, formulate, manufacture, promote and distribute a wide range of products to pest management professionals. With products for termite and general pest control - as well as turf and ornamental - the company sells to thousands of pest management professionals around the world.
Ensystex成立于1994年,由虫害防治运营商创建,旨在改变专业虫害防治行业的格局。Ensystex拥有合成、采购、配方、制造、推广和向虫害管理专业人员分销各种产品的专业知识。凭借白蚁和一般虫害防治以及草坪和观赏植物的产品,该公司向世界各地的数千名虫害管理专业人员销售产品。
Per the terms of the agreement, Ensystex will distribute Med-X's Nature-Cide portfolio of indoor and outdoor pest control solutions to a wide variety of professional pest management customers through its direct field representatives located throughout the United States. Products for distribution will include Nature-Cide All Purpose Concentrate, Pest Management X2 and Insecticidal Dust.
根据协议条款,Ensystex将通过其在美国各地的直接现场代表,向各种专业虫害管理客户分销Med-X的自然-Cide室内和室外虫害控制解决方案组合。分销的产品将包括自然-Cide多功能浓缩剂、害虫管理X2和杀虫粉尘。
"Ensystex has deep experience in the pest management industry, and their team believes in delivering the most effective products to their demanding professional customer base," said Jennifer Mills, President of Med-X. "Their mission to be the premier supplier of pest management products to the structural pest control industry strongly complements our existing national distribution coverage. The addition of our all-natural pest control solutions uniquely enables the use of insecticides without fear of harming the environment, helping to expand and diversify their portfolio. Our distribution partnership and mutual commitment to provide proven pest control solutions to pest management professionals will enable us to expand our reach and supply our solutions to an increasingly broad spectrum of customers."
Med-X的詹妮弗·米尔斯说:“Ensystex在虫害管理行业拥有丰富的经验,他们的团队相信向要求苛刻的专业客户群提供最有效的产品。他们的使命是成为结构虫害控制行业虫害管理产品的主要供应商,这有力地补充了我们现有的全国分销覆盖范围。我们全天然虫害控制解决方案的加入使杀虫剂的使用独一无二,而不必担心损害环境,有助于扩大和多样化他们的产品组合。我们的经销伙伴关系和共同承诺向虫害管理专业人员提供经过验证的虫害控制解决方案,将使我们能够扩大我们的覆盖范围,并向越来越广泛的客户提供我们的解决方案。
Shelley Moats of Ensystex added: "We look forward to the opportunity to carry Nature-Cide's range of environmentally friendly and effective solutions, introducing these additional tools to broaden our product line and help enhance our customers' pest management programs. Ensystex's focus has always been to provide our customers with cost-effective solutions and this partnership supports our desire to offer a high-quality, all-natural solution for their use."
Ensystex的Shelley Moats补充道:“我们期待着有机会利用自然-赛德的一系列环保和有效的解决方案,推出这些额外的工具来拓宽我们的产品线,并帮助增强我们客户的虫害管理计划。Ensystex的重点一直是为我们的客户提供具有成本效益的解决方案,这一合作伙伴关系支持了我们为他们提供高质量、全天然解决方案的愿望。”
About Med-X, Inc.
关于Med-X公司
Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit .
Med-X,Inc.是面向国际病虫害防治、健康和保健市场的全天然绿色场景解决方案的领先创新者。Med-X利用其多样化的自有品牌系列,提供使用全天然成分的传统化学和医药产品的安全替代品,其全面的市场进入战略包括在关键的国家市场提供集成的电子商务、实体经销商和现场服务。欲了解更多信息,请访问。
Disclaimer and Forward-Looking Statements
免责声明和前瞻性声明
The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the Regulation A+ Offering Circular Securities and Exchange Commission filings before making any investment in the Company. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.
Med-X,Inc.在此提供的证券具有很高的投机性。投资MED-X公司的股票。有很大的风险。这项投资只适用于那些能够承受全部投资损失的人。此外,投资者必须明白,一项投资可能在无限期内缺乏流动性。这些证券目前不存在公开市场,如果公开市场在此次发行后发展起来,它可能不会继续下去。你应该读一下法规A+发售通告在对该公司进行任何投资之前,向美国证券交易委员会提交文件。本新闻稿可能包含有关公司的预期业务业绩、经营结果、财务状况和其他方面的前瞻性陈述,用“预期”、“预期”、“预计”和“预测”等语言表达。请注意,此类陈述仅为估计,不能保证前瞻性陈述所陈述或暗示的结果将由公司实际实现。前瞻性陈述可能是基于被证明是错误的管理假设。本公司及其业务受到重大风险和非其控制的潜在事件的影响,这些风险和潜在事件将导致预期结果与实际结果之间存在重大差异,包括公司发生运营亏损和经历意外的重大不利事件。
Investor Relations Contact
投资者关系联系人
Lucas Zimmerman
Director
MZ Group - MZ North America
949-259-4987
MXRX@mzgroup.us
卢卡斯·齐默尔曼
董事
MZ集团-MZ北美
949-259-4987
邮箱:mxrx@mzgroup.us
SOURCE: Med-X, Inc.
资料来源:Med-X公司
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧